What's breaking now, across thousands of outlets.
Cell therapy manufacturing startup Cellares is defending itself against Bristol Myers Squibb after the drugmaker pulled out of a contract claiming Cellares’ commercial manufacturing technology was not up to scratch. Due to the partnership ending ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
It can take years for someone to be diagnosed with endometriosis. This can mean ongoing pain, repeated appointments, uncertainty and delayed treatment.
Rasonque’s speedy approval — just a month after a completed submission — represents a paradigm shift for a notoriously deadly cancer and begins what analysts see as a highly lucrative drug launch.
Building the conditions for young people to thrive.
(MedPage Today) -- For opioid overdose survivors, starting methadone was associated with a reduced risk of death during the subsequent year compared with starting buprenorphine-naloxone, a…
In a new podcast, an expert explains what you need to know about Cyclospora.
The Food and Drug Administration (FDA) on Wednesday approved a treatment for advanced pancreatic cancer, offering new life-extending care for patients with one of the most aggressive forms of cancer.
